Literature DB >> 27408448

Respiratory Distress Secondary to Rhabdomyosarcoma of the Tongue and Co-existent Choanal Atresia.

Rahul Chatopadhayay1, Preeti Tiwari2, A N Gangopadhyay3, Vaibhav Pandey4.   

Abstract

Whilst rhabdomyosarcoma (RMS) is the third most common solid tumour in children, congenital RMS of the tongue is extremely rare and usually present as painless progressive mass since birth (Dagher and Helman in Oncologist 4:34-44, 1999; Childs and Goudy in Int J Pediatr Otorhinolaryngol 5:126-128, 2010). In neonates, presentation with respiratory distress is unexpected as neonates are preferential nasal breathers and restricted oral breathing due to tumour usually poses no problem. We herein report a case of rhabdomyosarcoma of the tongue with co-existent unilateral choanal atresia, presenting with respiratory distress. The baby developed upper respiratory tract infection following which developed severe respiratory distress. Airway symptoms were precipitated as there was combined obstruction of both the nostrils due to infection or adenoid enlargement and unilateral chonal atresia. Treatment of respiratory distress in the presence of RMS and bilateral nasal pathology must first prioritise the security of the airway, before taking a multi-factorial approach to the therapy of the lingual mass (Childs and Goudy in Int J Pediatr Otorhinolaryngol 5:126-128, 2010). This case illustrates the importance of vigilance with respect to co-existent nasal pathology, in order to avoid the occurrence of complete airway obstruction. We therefore feel that any diagnosis of lingual RMS should warrant a formal examination of both nasal cavities.

Entities:  

Keywords:  Choanal atresia; Respiratory distress; Rhabdomyosarcoma tongue; Tongue tumour

Year:  2015        PMID: 27408448      PMCID: PMC4925587          DOI: 10.1007/s12663-015-0772-7

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  9 in total

Review 1.  Rhabdomyosarcoma: an overview.

Authors:  R Dagher; L Helman
Journal:  Oncologist       Date:  1999

2.  Congenital embryonal rhabdomyosarcoma of the tongue.

Authors:  K K Mohan; A Lal
Journal:  Anesth Analg       Date:  1992-06       Impact factor: 5.108

3.  Perinatal management of a neonate with airway obstruction caused by rhabdomyosarcoma of the tongue.

Authors:  V A Skelton; A Goodwin
Journal:  Br J Anaesth       Date:  1999-12       Impact factor: 9.166

4.  Embryonal rhabdomyosarcoma of the head and neck. Report on eighty-eight cases.

Authors:  J K Masson; E H Soule
Journal:  Am J Surg       Date:  1965-10       Impact factor: 2.565

5.  Rhabdomyosarcoma in childhood: a retrospective analysis of 190 patients treated at a single institution.

Authors:  Tarek Shouman; Ihab El-Kest; Khalid Zaza; Mohamad Ezzat; Hany William; Ibrahim Ezzat
Journal:  J Egypt Natl Canc Inst       Date:  2005-06

6.  Is fetal cellular rhabdomyoma an entity or a differentiated rhabdomyosarcoma? A study of patients with rhabdomyoma of the tongue and sarcoma of the tongue enrolled in the intergroup rhabdomyosarcoma studies I, II, and III.

Authors:  R Kodet; J Fajstavr; Z Kabelka; J Koutecky; T Eckschlager; W A Newton
Journal:  Cancer       Date:  1991-06-01       Impact factor: 6.860

7.  Embryonal rhabdomyosarcoma of the tongue.

Authors:  Antonietta Cirocco; Francisco González; Ana María Sáenz; César Jiménez; José R Sardi; Reyes F Oscar
Journal:  Pediatr Dermatol       Date:  2005 May-Jun       Impact factor: 1.588

8.  Management of bilateral choanal atresia in the neonate: an institutional review.

Authors:  C S Gujrathi; S J Daniel; A L James; Vito Forte
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2004-04       Impact factor: 1.675

9.  Rhabdomyosarcoma of the tongue.

Authors:  D C Doval; V Kannan; R S Acharya; G Mukherjee; A M Shenoy; P P Bapsy
Journal:  Br J Oral Maxillofac Surg       Date:  1994-06       Impact factor: 1.651

  9 in total
  1 in total

1.  Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis.

Authors:  Kristianne M Oristian; Lisa E S Crose; Nina Kuprasertkul; Rex C Bentley; Yi-Tzu Lin; Nerissa Williams; David G Kirsch; Corinne M Linardic
Journal:  Cancer Res       Date:  2018-08-09       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.